Results 51 to 60 of about 361,612 (191)

Direct projection from the suprachiasmatic nucleus to hypophysiotrophic corticotropin-releasing factor immunoreactive cells in the paraventricular nucleus of the hypothalamus demonstrated....

open access: yes, 1995
Suprachiasmatic nucleus, paraventricular nucleus, circadian rhythms, phaseolus vulgaris-leucoagglutinin, corticotropin-releasing factor, dual ...
Vrang, N., Mikkelsen, J.D., Larsen, P.J.
core   +1 more source

Effect of Social Rank on Gut Microbes and Their Metabolites of Greater Long‐Tailed Hamsters (Tscherskia triton)

open access: yesIntegrative Zoology, EarlyView.
Social rank in greater long‐tailed hamsters (Tscherskia triton) shapes gut microbiota composition and metabolite profiles. Dominant males exhibit a “high‐vigilance, metabolically activated” phenotype, with elevated aggression and specific gut microbiota enriched in energy‐harvesting taxa and fecal queuine.
Da Zhang, Xiaoming Xu, Zhibin Zhang
wiley   +1 more source

A hypothalamic-thalamostriatal circuit that controls approach-avoidance conflict in rats

open access: yesNature Communications, 2021
Animals constantly balance seeking food with avoiding predators. Here, the authors report that CRF positive neurons in the paraventricular thalamus projecting to the nucleus accumbens in rats are an indispensable component of a feedback circuit that can ...
D. S. Engelke   +7 more
doaj   +1 more source

Gut microbiota as a novel therapeutic target for eating disorders and obesity

open access: yesBritish Journal of Pharmacology, EarlyView.
The graphical abstract highlights the bidirectional interaction between the gut microbiota and central homeostatic and hedonic mechanisms regulating food intake, which contributes to overweight and obesity. It also illustrates emerging microbiota‐based biomarkers and therapeutic strategies (including prebiotics, probiotics, postbiotics, synbiotics and ...
Solveiga Samulėnaitė   +5 more
wiley   +1 more source

The role of nitric oxide on regeneration of paraventricular nucleus and supraoptic nucleus following hypophysectomy [PDF]

open access: yes, 2003
INTRODUCTION: The mammalian neurohypophyseal system exhibits a high degree of structural plasticity and recovery of neuroendocrine function following a broad array of physiological and anatomical manipulations.
So, KF, Wu, W, Yuan, QJ
core  

Evidence that 5-HT2A Receptors in the Hypothalamic Paraventricular Nucleus Mediate Neuroendocrine Responses to (-)DOI [PDF]

open access: yes, 2002
This is the publisher's version, also available electronically from "http://www.jneurosci.org".The present study determined whether the serotonin2A (5-HT2A) receptors in the hypothalamic paraventricular nucleus mediate the neuroendocrine responses to a ...
Hanley, Nicole R. Sullivan   +13 more
core   +1 more source

Topographical organization of the rat suprachiasmatic paraventricular projection

open access: yes, 1995
Suprachiasmatic nucleus, paraventricular nucleus, circadian ...
Vrang, N.   +3 more
core   +1 more source

Therapeutic access points: The roles of circumventricular organs in drug delivery and metabolic regulation

open access: yesBritish Journal of Pharmacology, EarlyView.
The current obesity drug landscape, dominated by GLP‐1 receptor agonists and emerging multi‐agonist therapies, has reinforced that long‐term weight loss is achieved in large part through central mechanisms that suppress appetite and reshape energy balance.
Ines Martinez‐Corral   +3 more
wiley   +1 more source

Example of RUNX2 immunolabeling in the suprachiasmatic nucleus (SCN) and paraventricular nucleus (PVN) in a representative adult male mouse at CT9.

open access: yes, 2013
The dotted lines outline the area of interest, the SCN in A and the PVN in B. Scale bar depicts 125 µm in A and 250 µm in B. Abbreviations: 3V: third ventricle; och: optic chiasm; PVN: paraventricular nucleus; SCN: suprachiasmatic nucleus.
Meghan E. Reale (286587)   +5 more
core   +1 more source

The ongoing oleoylethanolamide story: Therapeutic implications in the control of obesity and its comorbidities

open access: yesBritish Journal of Pharmacology, EarlyView.
The global burden of obesity continues to rise, demanding effective pharmacological strategies for individuals in whom prevention alone is insufficient. Recent incretin‐based and multi‐agonist therapies have delivered unprecedented weight loss, demonstrating that the simultaneous modulation of multiple metabolic pathways can optimize body weight ...
Marzia Friuli   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy